1. Annesi, G., Savettieri, G., Pugliese, P., D'Amelio, M., Tarantino, P., Ragonese, P., et al. (2005). DJ-1 mutations and parkinsonism–dementia–amyotrophic lateral sclerosis complex. Annals of Neurology, 58, 803–807.
2. Arthur, K. C., Doyle, C., Chiò, A., Traynor, B. J. (2016). Use of genetic testing in amyotrophic lateral sclerosis by neurologists. JAMA Neurology.
3. Borghero, G., Floris, G., Cannas, A., Marrosu, M. G., Murru, M. R., Costantino, E., et al. (2011). A patient carrying a homozygous p. A382T TARDBP missense mutation shows a syndrome including ALS, extrapyramidal symptoms, and FTD. NeurobiolAging, 32, e1–e5.
4. Brooks, B. R., Miller, R. G., Swash, M., Munsat, T. L., & World Federation of Neurology Research Group on Motor Neuron Diseases. (2000). El Escorial revisited: Revised criteria for diagnosis of amyotrophic lateral sclerosis. AmyotrophLateralSclerOther Motor NeuronDisord, 1, 293–299.
5. Chiò, A., Battistini, S., Calvo, A., The ITALSGEN Consortium, et al. (2014). Genetic counselling in ALS: Facts, uncertainties and clinical suggestions. J NeurolNeurosurgPsychiatry, 85, 478–485.